The Strategic Evolution of Monoclonal Antibody Therapies within the Canine Atopic Dermatitis Market in 2025
The veterinary landscape in late 2025 is being fundamentally transformed by a clinical shift away from broad-spectrum immunosuppressants toward highly targeted biological interventions. For decades, the management of skin allergies relied heavily on corticosteroids, which, while effective at stopping inflammation, often caused systemic side effects like increased thirst, weight gain, and...